The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ozempic, a 1 mg/dose (4 mg/3 ml) 3 ml medication, valued at $9,063.52. The contract has a firm fixed price and an ultimate completion date of December 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs. This delivery order is part of that larger IDC, which serves as a streamlined procurement vehicle for essential medical commodities across multiple therapeutic areas. The contract award did not utilize any set-aside designations, indicating open competition.
Generated 3/20/25, 9:54 AM